2 results  1 of 1 

1 Role of PCSK9 Inhibitors in Patients with Familial Hypercholesterolemia
Brian Tomlinson, Nivritti Gajanan Patil, Manson Fok, Christopher Wai Kei Lam
Endocrinol Metab.2021;36(2):279-295.   Published online 2021 April 19     DOI: http://dx.doi.org/10.3803/EnM.2021.964
      
2 Pharmacological Strategies beyond Statins: Ezetimibe and PCSK9 Inhibitors
Jah Yeon Choi, Jin Oh Na
J Lipid Atheroscler.2019;8(2):183-191.   Published online 2019 September 17     DOI: http://dx.doi.org/10.12997/jla.2019.8.2.183
      

 1 of 1